RESULTS: 7,619 women completed all questionnaires (83%). 3,507 had a history of breast conservation surgery (43%), 1,269 had mastectomy (16.67%), 2,328 underwent breast reconstruction (BR) (30.6%), and 515 had a complex surgical history (6.8%). Linear regression demonstrated that compared to BCS, patients who had a complex surgical history reported the most PTSD symptoms. There was no difference in PTSD symptoms, or incidence, with other surgical procedures, including mastectomy alone and all the reconstruction subtypes. Factors associated with an increase in PTSD symptoms included stage III disease, chemotherapy, obesity, and minor. Logarithmic regression displayed an increased incidence of PTSD with minor complications and unemployment and a decreased incidence with increasing age at diagnosis and increased time since initial operation.
PURPOSE:
Hospitals are evaluated for quality based on a number of metrics including the occurrence of complications. Urinary tract infections (UTI) are among the most common healthcare-associated infections, with the majority seen after prolonged urinary catheterization. The Enhanced Recovery After Surgery (ERAS) protocol calls for early removal of urinary catheters. In this study, we compare the rate of UTI in patients who have undergone traditional recovery after surgery (pre-ERAS) to those who were enrolled in the ERAS protocol (post-ERAS). We hypothesized that early catheter removal would decrease the rate of UTI in patients undergoing breast reconstruction with free flaps.
METHODS:
In this IRB approved study, medical records between March 2012 and June 2017 from a single institution were retrospectively evaluated to identify patients who underwent abdominal free flap breast reconstruction. This included patients seen before and after ERAS implementation, which occurred in May 2015. Early catheter removal was defined by our ERAS protocol as the morning of postoperative day 2. UTI was defined using the American College of Surgeons NSQIP definition. The incidence of UTI before and after ERAS initiation was compared using logistic regression while controlling for variables.
RESULTS:
There were 265 total patients evaluated. 159 patients were classified as pre-ERAS implementation and 106 were classified as post-ERAS implementation. The overall incidence of UTI for all patients who underwent free flap reconstruction was 3.9%. When controlling for age, BMI, length of operation, flap laterality and need for urinary catheter reinsertion, the rate of post-operative UTI was significantly higher in the post-ERAS cohort compared to the pre-ERAS cohort (7.5% vs. 1.3% p=0.04, OR=0.173). Additionally, the rate of urinary catheter reinsertion was predictive of post-operative UTI (p=0.005, OR=0.056). Finally, post-ERAS patients required a higher rate of urinary catheter reinsertion for urinary retention compared to pre-ERAS patients (p=0.02, OR=0.105).
CONCLUSION:
In contrast to our hypothesis, we found that the rate of UTI was significantly higher in the patients who underwent early catheter removal as part of the ERAS protocol. Further analysis is needed, however this finding may be related to higher rates of need for re-catheterization after early catheter removal. Based on these findings we are evaluating predictors of urinary retention in these patients to try to reduce the occurrence of UTI.
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The Impact of Post-Mastectomy Radiation Therapy on Permanent Implants in Direct-to-Implant Breast Reconstruction versus Tissue Expanders in Two-Stage Breast Reconstruction.
PURPOSE: Post-mastectomy radiotherapy (PMRT) plays a key role in influencing the reconstructive outcome of implant-based breast reconstruction. While some studies have reviewed the effects of PMRT on a tissue expander (TE) in two-stage breast reconstruction, few studies have assessed the impact of PMRT after direct-to-implant reconstructions (DTI) breast reconstruction. This study evaluates complications and reconstructive outcomes of PMRT in DTI compared to two-stage breast reconstruction.
METHODS:
Single-institution retrospective review of immediate implant-based breast reconstruction patients that received post-mastectomy radiotherapy from 2006-2014 with a minimum of a 2-year follow-up were reviewed. All patients who received preoperative radiotherapy were excluded.
RESULTS:
Out of the 1671 patients, 265 patients were identified to have received post-mastectomy radiation. Of the 265, 149 received DTI and 116 had two-stage tissue expander to implant (TE-I) reconstruction. The overall mean age was 46.5 and BMI 26.9. There were no significant differences in demographics except more smokers in the TE group (7.7% vs. 1.3%, p=0.009). The DTI group had a significantly higher use of Alloderm compared to the TE group (72.5% vs. 41.4%, p<0.001). Patients who received PMRT with a tissue expander in place had more complications (32.7% vs. 10.7%, p<0.001), skin-necrosis (10.3% vs 4.0%, p<0.001), wound breakdown (9.5% vs. 2.0%, p=0.011) and infections (16.3% vs. 4.03%, p<0.001) leading to a higher rate of explantation (16.3% vs. 3.3%, p<0.001). When comparing the reconstructive outcomes, the TE group had a higher failure rate (20.6% vs. 10.7%, p=0.025). However we found the revision for capsular contracture rates to be similar between the two cohorts (11.4% vs. 10.3%, p=0.783) as well as revision rates for contour asymmetry, size mismatch and malposition. Subgroup analysis of DTI with ADM vs. TE-I with ADM showed similar complication findings; however, the DTI group had significantly higher revision rates (21.1% vs. 7.4%, p=0.029). In our multivariate regression analysis, radiation to the TE had a higher risk of reconstruction failure than radiation after DTI reconstruction (OR 2.004, 95% CI: 0.987-4.067, p=0.05).
CONCLUSION:
The optimal timing of post-mastectomy radiotherapy on implant-based breast reconstruction remains to be determined. Our study showed that PMRT after directto-implant breast reconstruction had a lower reconstructive failure rate compared to two-stage reconstruction. 
PURPOSE:
The aim of this study was to evaluate postoperative satisfaction and quality of life in women who chose to undergo contralateral prophylactic mastectomy (CPM) with reconstruction compared to those opting for unilateral procedures.
METHODS:
Women undergoing immediate breast reconstruction at Montefiore Medical Center between June 2015 and September 2017 were prospectively enrolled in this study. For analysis, women were divided into two groups: those undergoing unilateral reconstruction and those undergoing bilateral reconstruction with CPM indication. Patient demographics, body mass index (BMI), cancer characteristics, adjuvant therapy, mastectomy weight, and complication rates were analyzed with bivariate statistics (t-tests, Mann-Whitney, and Chi-Square as appropriate). Preoperative and postoperative BREAST-Q survey scores were compared between groups using t-tests or Mann-Whitney tests after assessing for normality of score distribution.
